A White House deal with Eli Lilly & Co. and Novo Nordisk to lower the prices of their popular obesity medicines, Zepbound and Wegovy, is a step toward making them more affordable and accessible to Americans — but until we have more details, it’s hard to tell how big a step it really is.
www.bloomberg.com
#Obesity #Drugs #White #House #Deal #Start
Obesity Drugs for All? White House Deal Is Just a Start
